On Tuesday, Soleno Therapeutics Inc (NASDAQ: SLNO) was 3.38% up from the session before settling in for the closing price of $81.42. A 52-week range for SLNO has been $36.93 – $81.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 20.19% over the last five years. When this article was written, the company’s average yearly earnings per share was at 36.96%. With a float of $41.75 million, this company’s outstanding shares have now reached $48.53 million.
The firm has a total of 92 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Soleno Therapeutics Inc (SLNO) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Soleno Therapeutics Inc stocks. The insider ownership of Soleno Therapeutics Inc is 17.15%, while institutional ownership is 94.85%. The most recent insider transaction that took place on Jun 24 ’25, was worth 22,410. Before that another transaction happened on Apr 01 ’25, when Company’s insider sold 3,782 for $70.11, making the entire transaction worth $265,156. This insider now owns 27,036 shares in total.
Soleno Therapeutics Inc (SLNO) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.96% per share during the next fiscal year.
Soleno Therapeutics Inc (NASDAQ: SLNO) Trading Performance Indicators
You can see what Soleno Therapeutics Inc (SLNO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 19.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.62, a number that is poised to hit -0.81 in the next quarter and is forecasted to reach 1.07 in one year’s time.
Technical Analysis of Soleno Therapeutics Inc (SLNO)
Analysing the last 5-days average volume posted by the [Soleno Therapeutics Inc, SLNO], we can find that recorded value of 1.45 million was better than the volume posted last year of 0.98 million. As of the previous 9 days, the stock’s Stochastic %D was 85.21%.
During the past 100 days, Soleno Therapeutics Inc’s (SLNO) raw stochastic average was set at 97.19%, which indicates a significant increase from 89.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 27.40% in the past 14 days, which was lower than the 70.82% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $75.35, while its 200-day Moving Average is $57.22. Now, the first resistance to watch is $86.13. This is followed by the second major resistance level at $88.09. The third major resistance level sits at $90.82. If the price goes on to break the first support level at $81.44, it is likely to go to the next support level at $78.71. Should the price break the second support level, the third support level stands at $76.75.
Soleno Therapeutics Inc (NASDAQ: SLNO) Key Stats
There are 50,394K outstanding shares of the company, which has a market capitalization of 4.24 billion. As of now, sales total 0 K while income totals -175,850 K. Its latest quarter income was 0 K while its last quarter net income were -43,770 K.
